Page last updated: 2024-10-30

mepivacaine and Acute Lung Injury

mepivacaine has been researched along with Acute Lung Injury in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schley, MT1
Casutt, M1
Haberthür, C1
Dusch, M1
Rukwied, R1
Schmelz, M1
Schmeck, J1
Schüpfer, GK1
Konrad, CJ1

Other Studies

1 other study available for mepivacaine and Acute Lung Injury

ArticleYear
Long-acting local anesthetics attenuate FMLP-induced acute lung injury in rats.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:3

    Topics: Acute Lung Injury; Amides; Anesthesia, Local; Animals; Anti-Inflammatory Agents; Bupivacaine; Endoth

2009